DailySand tracks drug discovery across AI, semiconductor infrastructure, capital markets, and critical minerals supply chains. Below are curated source items and daily digests where drug discovery appears in today's cross-sector intelligence briefing.
1 item across 1 digest
Novo Nordisk selected AWS as its preferred cloud provider and strategic AI partner to deploy agentic AI across drug discovery, target identification, and therapy design workflows. This partnership signals pharmaceutical-scale adoption of autonomous AI agents, expanding the enterprise addressable market for cloud-based AI infrastructure beyond traditional software sectors.
Read original →
DailySand